ADVM logo

ADVM

Adverum Biotechnologies Inc.

$3.08
+$0.05(+1.65%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$66.31M
Volume
65.63K
52W Range
$1.78 - $8.56
Target Price
$19.75
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$2.3M$1.5M$1.8M$1.6M$250.0K--$7.5M--$3.6M$1.0M
Total Revenue
$2.3M$1.5M$1.8M$1.6M$250.0K--$7.5M--$3.6M$1.0M
COST OF GOODS SOLD
Cost of Revenue
$-100.0K$-600.0K$-500.0K$-100.0K------------
GROSS PROFIT
Gross Profit
$2.3M$1.5M$1.8M$1.6M$250.0K--$7.5M--$3.6M$1.0M
OPERATING EXPENSES
Operating Expenses
$-50.1M$-116.7M$-60.7M$-79.7M$-68.8M$118.0M$153.6M$157.1M$132.5M$140.2M
Research & Development
$25.5M$31.7M$39.8M$50.1M$40.4M$73.3M$89.2M$99.3M$77.5M$77.0M
Research Expense
$25.5M$31.7M$39.8M$50.1M$40.4M$73.3M$89.2M$99.3M$77.5M$77.0M
Selling, General & Administrative
$22.1M$24.4M$20.9M$24.6M$28.4M$44.6M$64.4M$57.9M$55.1M$63.1M
General & Administrative Expenses
$22.1M$24.4M$20.9M$24.6M$28.4M$44.6M$64.4M$57.9M$55.1M$63.1M
Salaries & Wages
$-11.5M$-11.4M$-8.7M$-13.4M$-9.9M$300.0K$1.6M------
Depreciation & Amortization
$-812.0K$-1.6M$-2.1M$-1.8M$-1.6M$4.2M--------
Depreciation & Amortization
$-812.0K$-1.6M$-2.1M$-1.8M$-1.6M$4.2M--------
Other Operating Expenses
$-50.1M$-116.7M$-60.7M$-4.1M$-995.0K$-5.1M$-2.6M$-2.5M----
OPERATING INCOME
Operating income
$-45.3M$-54.6M$-58.8M$-73.1M$-68.5M$-118.0M$-146.1M$-157.1M$-128.9M$-139.2M
EBITDA
$-45.9M$-112.9M$-53.5M$-72.1M$-64.2M$-113.8M$-141.5M$-150.6M$-99.3M$-119.8M
NON-OPERATING ITEMS
Intinc
------$4.2M$4.1M----------
Net Non-Operating Interest Income/Expense
------$4.2M$4.1M----------
Gain on Sale of Securities
$-6.0K$6.0K$-182.0K$168.0K$33.0K----------
Other Income/Expense
$-364.0K$-768.0K$-2.5M$-168.0K$-33.0K$-1.6M$-154.0K$2.7M$-6.8M$-8.3M
Other Special Charges
$370.0K$762.0K$2.7M$4.2M--$1.6M$582.0K$2.7M$5.7M$8.2M
SPECIAL ITEMS
Restructring And Mn A Income
$2.6M------------$4.7M----
Special Income Charges
$-2.6M$-60.7M--$-5.0M----$-1.1M$-6.8M$-224.0K--
Impairment of Capital Assets
--$60.7M--$5.0M----$1.1M$2.1M----
PRE-TAX INCOME
EBIT
$-47.5M$-114.5M$-56.1M$-73.9M$-64.5M$-118.0M$-146.1M$-157.1M$-123.2M$-130.9M
Pre-Tax Income
$-47.5M$-114.5M$-56.1M$-73.9M$-64.5M$-116.4M$-145.5M$-154.5M$-123.2M$-130.9M
INCOME TAX
Tax Provision
--$-775.0K$-10.2M$-1.3M$-298.0K$1.1M$-7.0K$74.0K$-1.1M--
NET INCOME
Net Income
$-47.5M$-113.7M$-56.3M$-72.5M$-64.5M$-117.5M$-145.5M$-154.5M$-122.1M$-130.9M
Net Income (Continuing Operations)
$-47.5M$-113.7M$-56.3M$-72.5M$-64.5M$-117.5M$-145.5M$-154.5M$-122.1M$-130.9M
Net Income (Discontinued Operations)
$-47.5M$-113.7M$-56.3M$-72.5M$-64.5M$-117.5M$-145.5M$-154.5M$-122.1M$-130.9M
Net Income (Common Stockholders)
$-47.5M$-113.7M$-56.3M$-72.5M$-64.5M$-117.5M$-145.5M$-154.5M$-122.1M$-130.9M
TOTALS
Total Expenses
$-50.2M$-117.3M$-61.2M$79.7M$-68.8M$118.0M$153.6M$157.1M$132.5M$140.2M
SHARE & EPS DATA
Average Shares Outstanding
$25.5M$36.2M$43.7M$61.4M$64.1M$85.1M$98.0M$9.9M$10.1M$19.8M
Average Shares Outstanding (Diluted)
$25.5M$36.2M$43.7M$61.4M$63.8M$85.1M$98.0M$9.9M$10.1M$19.8M
Shares Outstanding
$26.9M$42.1M$62.2M$63.2M$79.7M$9.8M$9.9M$10.1M$20.8M$20.9M
Basic EPS
----------$-1.38$-1.48$-15.6$-11.6$-6.62
Basic EPS (Continuing Operations)
----------$-1.38$-1.48$-15.6$-11.6$-6.62
Diluted EPS
$-1.86$-3.14$-1.29$-1.18$-1.01$-1.38$-1.48$-15.6$-11.6$-6.62
Diluted EPS (Continuing Operations)
------------$-1.48$-15.6$-11.6$-6.62
OTHER METRICS
Other Gand A
$22.1M$24.4M$20.9M$24.6M$28.4M$44.6M$64.4M$57.9M$55.1M$63.1M
Other Impairment Of Capital Assets
--$-11.2M--------$800.0K------
Rent And Landing Fees
$22.1M$24.4M$20.9M$24.6M$28.4M----------
Restruct
$2.6M------------$4.7M----

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ADVM$3.08+1.7%65.63K
3
4
5
6

Get Adverum Biotechnologies Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.